Selank for Depression: What the Research Actually Shows

Selank for depression has no strong human evidence behind it. Here's what research shows about this Russian peptide, its safety, dosage, and legal status.

ARTICLE OVERVIEW

Selank for depression has no strong human evidence behind it. Here's what research shows about this Russian peptide, its safety, dosage, and legal status.

Selank is a synthetic heptapeptide developed in Russia and sold online as an anxiolytic and nootropic, but there is no reliable human evidence that it treats depression, and it is not FDA-approved for any medical use in the United States. Small Russian studies and rodent experiments hint at anxiety-reducing and mood-related effects, yet no large placebo-controlled human trial has tested Selank specifically in people with depressive disorders. Anyone weighing it as a treatment should speak with a licensed healthcare professional first.

What Is Selank?

Selank is a seven-amino-acid peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) modeled on tuftsin, a naturally occurring immunomodulatory fragment. It was developed at the Institute of Molecular Genetics in Moscow and is most often studied as an intranasal spray.

In Russian medical literature, Selank is described as an anxiolytic with mild nootropic and anti-asthenic properties. Outside Russia, it is widely sold as a research chemical rather than a medicine.

  • Class: synthetic peptide, tuftsin analog
  • Common route: intranasal drops or spray
  • Reported uses: anxiety, stress, fatigue, focus
  • US status: not FDA-approved for human use

Why People Look Into Selank for Depression

Depression and anxiety overlap heavily, and Selank's best-documented effects are anxiolytic. That overlap is the main reason researchers and self-experimenters ask whether Selank for depression is even plausible.

Preclinical work suggests Selank may influence GABA-A receptor expression, monoamine turnover, and BDNF-related signaling in the hippocampus. Those pathways matter in mood disorders, which is why the hypothesis exists at all.

Selank is also appealing because it is described as non-sedating and non-habituating, unlike benzodiazepines. That profile looks attractive on paper, but attractive pharmacology is not the same as proven clinical benefit.

What the Evidence Actually Shows

The honest summary is that Selank's depression evidence is thin, indirect, and mostly preclinical.

Evidence typeWhat was foundKey limitations
Rodent studiesAntidepressant-like behavior in forced-swim and chronic stress modelsAnimal models do not reliably predict human antidepressant response
Russian human trialsReduced anxiety and improved asthenia scores in small samplesSmall samples, rarely blinded, not depression-specific, limited English-language peer review
Human depression trialsNone identifiedNo randomized controlled trial has tested Selank as a depression treatment
Long-term safety dataEssentially noneNo multi-year human safety or drug interaction data

No published randomized controlled trial has tested Selank as a treatment for major depressive disorder. Claims that Selank cures or treats depression are not supported by the current literature.

Selank Compared With Other Compounds

CompoundMain research interestTypical routeUS regulatory status
SelankAnxiety, mood, focusIntranasalNot FDA-approved
SemaxCognition, stroke recovery, attentionIntranasalNot FDA-approved
BPC-157Soft-tissue and gut repair modelsSubcutaneous, oralNot FDA-approved
SSRIs such as sertralineDepression and anxietyOralFDA-approved

The comparison matters because approved antidepressants have decades of controlled data behind them, while Selank does not. People researching growth-hormone secretagogues often ask what is cjc 1295 ipamorelin used for, but that is a completely different mechanism from Selank's proposed GABA and monoamine activity.

Dosage, Reconstitution, and Storage

Russian protocols commonly describe 250 to 500 mcg intranasally once to three times daily for 10 to 14 days. That is a research convention, not an established human dose, and it should not be treated as medical guidance.

Selank is usually shipped as a lyophilized powder. In a laboratory setting, it is typically reconstituted with bac water for injection and then stored refrigerated and protected from light.

Handling details matter here. Supplier documentation generally answers how long is bac water good for once opened, and the common figure is about 28 days after the first puncture. Solubility also varies by peptide, so some compounds call for acetic acid for aod 9604 instead of a plain aqueous diluent. Always check the specific datasheet rather than assuming one solvent fits every powder.

Vendors marketing the best bac water for peptides are selling a handling supply, not a therapeutic product, and quality documentation across sellers varies widely.

Selank is not FDA-approved for human use in the United States. It is not a lawful prescription medication, and products sold online are unregulated, which means identity, purity, and sterility are not guaranteed.

Reported side effects in small studies include headache, irritability, dizziness, nasal irritation, and fatigue. Because human exposure data are limited, long-term effects and interactions with other drugs remain unknown.

Selank has no established role in the treatment of depression, and it should not be used as a substitute for evidence-based care such as therapy, lifestyle treatment, or FDA-approved medication.

If you are struggling with depression, contact a healthcare professional or a crisis line. In the US, you can call or text 988 for the Suicide and Crisis Lifeline.

Bottom Line on Selank for Depression

  • Selank is a Russian synthetic peptide researched mainly for anxiety, not depression.
  • No randomized controlled trial has tested Selank as a depression treatment in humans.
  • Selank is not FDA-approved for any human use in the United States.
  • Reported benefits come from small, mostly Russian studies and animal models.
  • Approved antidepressants and psychotherapy remain the evidence-based options for depression.

Frequently Asked Questions

Does Selank actually help with depression?

There is no reliable human evidence that Selank treats depression. Rodent studies show antidepressant-like effects, and small Russian trials suggest it reduces anxiety, but no randomized controlled trial has tested it in people with major depressive disorder.

Is Selank legal to buy in the US?

Selank is not FDA-approved for human use in the United States. It is commonly sold as a research chemical, which means it is not regulated as a drug and purity, sterility, and dose accuracy are not guaranteed.

What is a typical Selank dosage?

Russian research protocols often describe 250 to 500 mcg intranasally once to three times daily for 10 to 14 days. No FDA-approved or clinically established human dose exists, so those figures are research conventions rather than medical recommendations.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.